Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
75,607,738
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
31,217,200
-
Shares change
-
+31,217,200
-
Total reported value, excl. options
-
$676,785,000
-
Value change
-
+$676,785,000
-
Number of buys
-
43
-
Price
-
$21.68
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q3 2019
As of 30 Sep 2019 SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) had 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,217,200 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, BVF INC/IL, BOXER CAPITAL, LLC, CITADEL ADVISORS LLC, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Samsara BioCapital, LLC, and ArrowMark Colorado Holdings LLC.
This table shows 44 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.